Risk of not receiving second-line therapy is high in EGFR mt plus patients: Real-world data of certified lung cancer centers on treatment sequence in EGFR mt plus patients
Journal article published in 2019 by
J. Roeper,
A. C. Lueers,
M. Falk,
S. Schatz,
M. Tiemann,
C. Wesseler 
,
G. H. Wiest,
S. Sackmann,
D. Ukena,
L. Heukamp,
F. Griesinger
,
G. H. Wiest,
S. Sackmann,
D. Ukena,
L. Heukamp,
F. Griesinger
